NOV Inc. (NOV)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 831,000 767,000 749,000 632,000 612,000 618,000 526,000 418,000 238,000 68,000 -56,000 -145,000 -230,000 -527,000 -581,000 -694,000 -2,779,000 -2,884,000 -2,959,000 -8,582,000
Revenue (ttm) US$ in thousands 8,869,000 8,899,000 8,893,000 8,770,000 8,578,000 8,313,000 8,017,000 7,651,000 7,237,000 6,681,000 6,133,000 5,823,000 5,524,000 5,334,000 5,377,000 5,456,000 6,090,000 7,044,000 7,786,000 8,422,000
Pretax margin 9.37% 8.62% 8.42% 7.21% 7.13% 7.43% 6.56% 5.46% 3.29% 1.02% -0.91% -2.49% -4.16% -9.88% -10.81% -12.72% -45.63% -40.94% -38.00% -101.90%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $831,000K ÷ $8,869,000K
= 9.37%

NOV Inc.'s pretax margin has exhibited a significant improvement over the analyzed period from March 31, 2020, to December 31, 2024. At the beginning of the period, the company experienced negative pretax margins, with figures as low as -101.90% in March 2020, indicating that expenses exceeded its gross income.

However, the company gradually improved its performance, managing to reduce its pretax losses quarter by quarter. The pretax margin turned positive in the third quarter of 2022, marking a turning point for NOV Inc.'s financial performance. The positive trend continued, with the pretax margin consistently increasing until reaching a peak of 9.37% by December 2024.

This improvement in pretax margin reflects the company's efforts in controlling costs, increasing operational efficiency, and potentially generating higher revenues. A rising pretax margin indicates that NOV Inc. is becoming more profitable before accounting for taxes, which is a positive sign for potential investors and stakeholders in evaluating the company's financial health and performance.